-
Loading metrics
Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives
- Alejandro Arrieta,
- Timothy F. Page,
- Emir Veledar,
- Khurram Nasir
x
- Published: January 12, 2017
- https://doi.org/10.1371/journal.pone.0169761